150 related articles for article (PubMed ID: 1823174)
21. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents.
Puttagunta NR; Gibby WA; Smith GT
Invest Radiol; 1996 Dec; 31(12):739-42. PubMed ID: 8970874
[TBL] [Abstract][Full Text] [Related]
22. Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI.
Unger EC; MacDougall P; Cullis P; Tilcock C
Magn Reson Imaging; 1989; 7(4):417-23. PubMed ID: 2811620
[TBL] [Abstract][Full Text] [Related]
23. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
[TBL] [Abstract][Full Text] [Related]
24. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.
Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E
Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598
[TBL] [Abstract][Full Text] [Related]
25. Nuclear magnetic relaxation dispersion profiles of aqueous solutions of a series of Gd(NOTA) analogs.
Geraldes CF; Brown RD; Brucher E; Koenig SH; Sherry AD; Spiller M
Magn Reson Med; 1992 Oct; 27(2):284-95. PubMed ID: 1334203
[TBL] [Abstract][Full Text] [Related]
26. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
27. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P
Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
[TBL] [Abstract][Full Text] [Related]
28. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent.
Niemi P; Koskinen S; Reisto T
Invest Radiol; 1991 Jul; 26(7):674-80. PubMed ID: 1885276
[TBL] [Abstract][Full Text] [Related]
29. Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties.
Allard M; Doucet D; Kien P; Bonnemain B; Caillé JM
Invest Radiol; 1988 Sep; 23 Suppl 1():S271-4. PubMed ID: 3198361
[TBL] [Abstract][Full Text] [Related]
30. The effects of gadolinium-DTPA and -DOTA on neural tissue metabolism.
Morris TW; Ekholm SE; Prentice LI
Invest Radiol; 1991 Dec; 26(12):1087-90. PubMed ID: 1765443
[TBL] [Abstract][Full Text] [Related]
31. Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.
Nwe K; Bernardo M; Regino CA; Williams M; Brechbiel MW
Bioorg Med Chem; 2010 Aug; 18(16):5925-31. PubMed ID: 20663676
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and stability of caldiamide sodium in rats.
Okazaki O; Kurata T; Yoshioka N; Hakusui H
Arzneimittelforschung; 1996 Jan; 46(1):79-83. PubMed ID: 8821523
[TBL] [Abstract][Full Text] [Related]
33. The use of magnetic resonance imaging to track controlled drug release and transport in the brain.
Reisfeld B; Blackband S; Calhoun V; Grossman S; Eller S; Leong K
Magn Reson Imaging; 1993; 11(2):247-52. PubMed ID: 8455434
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
35. Slow clearance gadolinium-based extracellular and intravascular contrast media for three-dimensional MR angiography.
Bremerich J; Colet JM; Giovenzana GB; Aime S; Scheffler K; Laurent S; Bongartz G; Muller RN
J Magn Reson Imaging; 2001 Apr; 13(4):588-93. PubMed ID: 11276103
[TBL] [Abstract][Full Text] [Related]
36. Distribution and chemical forms of gadolinium in the brain: a review.
Kanda T; Nakai Y; Hagiwara A; Oba H; Toyoda K; Furui S
Br J Radiol; 2017 Nov; 90(1079):20170115. PubMed ID: 28749164
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and biodistribution study of self-assembled Gd-micelles demonstrating blood-pool contrast enhancement for MRI.
Vorobiev V; Babič A; Crowe LA; Van De Looij Y; Lenglet S; Thomas A; Helm L; Vallée JP; Allémann E
Int J Pharm; 2019 Sep; 568():118496. PubMed ID: 31279053
[TBL] [Abstract][Full Text] [Related]
38. Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging.
Anelli PL; Lattuada L; Lorusso V; Lux G; Morisetti A; Morosini P; Serleti M; Uggeri F
J Med Chem; 2004 Jul; 47(14):3629-41. PubMed ID: 15214790
[TBL] [Abstract][Full Text] [Related]
39. Gd accumulation in tissues of healthy mice upon repeated administrations of Gadodiamide and Gadoteridol.
Di Gregorio E; Iani R; Ferrauto G; Nuzzi R; Aime S; Gianolio E
J Trace Elem Med Biol; 2018 Jul; 48():239-245. PubMed ID: 29773187
[TBL] [Abstract][Full Text] [Related]
40. Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents.
Lin J; Idee JM; Port M; Diai A; Berthommier C; Robert M; Raynal I; Devoldere L; Corot C
J Pharm Biomed Anal; 1999 Dec; 21(5):931-43. PubMed ID: 10703961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
